OTCMKTS:STDAF STADA Arzneimittel Aktiengesellschaft (STDAF) Stock Price, News & Analysis → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free STDAF Stock Alerts $110.42 0.00 (0.00%) (As of 10/24/2022) Add Compare Share Share Today's Range$110.42▼$110.4250-Day Range$110.42▼$110.4252-Week Range$75.15▼$115.00VolumeN/AAverage Volume180 shsMarket Capitalization$6.88 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get STADA Arzneimittel Aktiengesellschaft alerts: Email Address Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW About STADA Arzneimittel Aktiengesellschaft Stock (OTCMKTS:STDAF)STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Read More STDAF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STDAF Stock News HeadlinesFebruary 22, 2024 | washingtonpost.comSTAFF NEWSJanuary 10, 2024 | seekingalpha.comKPLUY K+S AktiengesellschaftApril 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.January 10, 2024 | seekingalpha.comKPLUY K+S AktiengesellschaftJuly 21, 2023 | investing.comSTADA Arzneimittel AG V (SAZA)May 30, 2023 | bbc.co.ukCBI hired 'toxic' staff and failed to sack offendersJanuary 28, 2023 | seekingalpha.comSartorius Aktiengesellschaft 2022 Q4 - Results - Earnings Call PresentationSee More Headlines Receive STDAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:STDAF Previous SymbolNASDAQ:STDAF CUSIPN/A CIKN/A Webwww.stada.com Phone(496) 101-6030Fax49-61-0160-3259Employees12,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.23 Current Ratio1.54 Quick Ratio0.99 Sales & Book Value Annual Sales$3.84 billion Price / Sales1.79 Cash Flow$11.12 per share Price / Cash Flow9.93 Book Value$23.11 per share Price / Book4.78Miscellaneous Outstanding Shares62,342,000Free FloatN/AMarket Cap$6.88 billion OptionableNot Optionable Beta0.38 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesPeter GoldschmidtChairman-Executive BoardWolfgang OlligChief Financial OfficerMiguel Pagan FernandezChief Technical OfficerYann BrunEVP, Head-Regulatory & Business DevelopmentFrank SeilerHead-Investor Relations ContactKey CompetitorsExelixisNASDAQ:EXELJazz PharmaceuticalsNASDAQ:JAZZCytokineticsNASDAQ:CYTKHealthEquityNASDAQ:HQYGlobus MedicalNYSE:GMEDView All Competitors STDAF Stock Analysis - Frequently Asked Questions How have STDAF shares performed in 2024? STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 on January 1st, 2024. Since then, STDAF stock has increased by 0.0% and is now trading at $110.42. View the best growth stocks for 2024 here. How do I buy shares of STADA Arzneimittel Aktiengesellschaft? Shares of STDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:STDAF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STADA Arzneimittel Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
